Stay updated on Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page header.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check51 days agoChange DetectedOnly administrative metadata and revision notes were updated or removed; the ClinicalTrials.gov study content, eligibility criteria, outcomes, and trial timeline remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedA site-wide notice about a lapse in government funding was added, and the page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check66 days agoChange DetectedAdded 'Show glossary' option and a new revision notice (v3.4.0); updated capitalization of labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', while removing older variants like 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check80 days agoChange DetectedRevision metadata updated: added v3.3.4 and removed v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.